Ji Hongwei, Xiong Jing, Yu Shikai, Chi Chen, Fan Ximin, Bai Bin, Zhou Yiwu, Teliewubai Jiadela, Lu Yuyan, Xu Henry, Zhang Yi, Xu Yawei
Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
BMJ Open. 2017 Mar 29;7(3):e013880. doi: 10.1136/bmjopen-2016-013880.
Cardiovascular (CV) diseases are the leading cause of death and disability in the world. Increasing lifespans and ageing populations also contribute to an increasing CV burden. However, in China, there were few well-designed cohort studies focusing on the elderly population, let alone an established CV risk score. The objective of this study is to establish a CV risk score based on a community-dwelling Chinese elderly population, determining the profile of the associated CV risk factors and target organ damages (TODs), so as to guide the later intervention.
The Northern Shanghai Study is an ongoing prospective community-based study. After enrolment, clinical examination, anthropometric measurement and a questionnaire will be administered to each participant at baseline and after every 2 years in the follow-up. Our tests and examinations include: blood/urine sample and biochemical measurements, office blood pressure recording, carotid ultrasonograph, echocardiograph, pulse wave velocity, pulse wave analysis, 4-limb blood pressure recording, body mass index, etc. Baseline measurement will also include the assessments on TODs and the conventional CV risk factors. In the follow-up, the incidence of CV events and mortality will be recorded. The Northern Shanghai Risk Score will be calculated, with considerations on CV risk factors and TODs.
This study was approved by the Shanghai Tenth People's Hospital Institutional Review Board. All participants signed a written consent form.
NCT02368938; Pre-results.
心血管疾病是全球死亡和残疾的主要原因。寿命延长和人口老龄化也导致心血管负担不断增加。然而,在中国,针对老年人群体的精心设计的队列研究很少,更不用说已建立的心血管风险评分了。本研究的目的是基于居住在社区的中国老年人群体建立一个心血管风险评分,确定相关心血管危险因素和靶器官损害(TODs)的特征,以便指导后续干预。
上海北部研究是一项正在进行的基于社区的前瞻性研究。入组后,将在基线时以及随访期间每2年对每位参与者进行临床检查、人体测量并发放问卷。我们的测试和检查包括:血液/尿液样本及生化检测、诊室血压记录、颈动脉超声、超声心动图、脉搏波速度、脉搏波分析、四肢血压记录、体重指数等。基线测量还将包括对TODs和传统心血管危险因素的评估。在随访中,将记录心血管事件的发生率和死亡率。将计算上海北部风险评分,同时考虑心血管危险因素和TODs。
本研究已获得上海市第十人民医院机构审查委员会的批准。所有参与者均签署了书面知情同意书。
NCT02368938;初步结果。